Edition:
United Kingdom

Kangmei Pharmaceutical Co Ltd (600518.SS)

600518.SS on Shanghai Stock Exchange

22.10CNY
11 Dec 2017
Change (% chg)

¥0.24 (+1.10%)
Prev Close
¥21.86
Open
¥21.88
Day's High
¥22.17
Day's Low
¥21.75
Volume
13,640,181
Avg. Vol
19,370,809
52-wk High
¥23.90
52-wk Low
¥16.95

Select another date:

Wed, Dec 6 2017

BRIEF-Kangmei Pharmaceutical in deal to invest 5 bln yuan in Guizhou

* SAYS IT SIGNS STRATEGIC AGREEMENT TO INVEST 5.0 BILLION YUAN ($756.06 million) IN GUIZHOU ON AREAS INCLUDING CHINESE MEDICINE RESEARCH, HEALTH BIG DATA Source text in Chinese: http://bit.ly/2Avc4TM Further company coverage: ($1 = 6.6132 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)

BRIEF-Kangmei Pharmaceutical's controlling shareholder issues 2017 second tranche exchangeable bonds worth 3 bln yuan

* Says its controlling shareholder issues 2017 second tranche non-public exchangeable bonds worth 3 billion yuan, with a term of three years

BRIEF-Kangmei Pharmaceutical says controlling shareholder issues 2017 1st tranche non-public exchangeable bonds worth 2 bln yuan

* Says co's controlling shareholder, an industry investment firm, issued 2017 first tranche non-public exchangeable bonds worth 2 billion yuan, with term of 3 years

BRIEF-Kangmei Pharmaceutical , BGI Genomics in strategic agreement

Oct 31 Kangmei Pharmaceutical Co Ltd , BGI Genomics Co LTd

BRIEF-Kangmei Pharmaceutical issues 2017 third tranche mid-term bills worth 2 bln yuan

* Says it issued 2017 third tranche mid-term bills worth 2 billion yuan with a term of 5 years, and coupon rate of 5.47 percent

BRIEF-Kangmei Pharmaceutical adopts new accounting policies

* Says it adopts new accounting policies regarding government subsidy, and non-current assets, disposal group and discontinued operations

BRIEF-Kangmei Pharmaceutical unit plans two 80-pct-owned medical equipment JVs with partner

* Says its unit plans to invest totaling 16 million yuan to set up two medical equipment JVs with partner, and will own a 80 percent stake in JVs respectively

BRIEF-Kangmei Pharmaceutical unit to buy medical sci-tech firm for 1.8 mln yuan

* Says its wholly owned pharma subsidiary plans to fully acquire a Hainan-based medical sci-tech firm for about 1.8 million yuan

BRIEF-Kangmei Pharmaceutical's H1 net profit up 21.83 pct y/y

* Says H1 net profit up 21.83 percent y/y at 2.15 billion yuan ($324.87 million)

BRIEF-Kangmei Pharma's controlling shareholder to issue up to 5.0 bln yuan exchangeable bonds

* Says controlling shareholder plans to issue up to 5.0 billion yuan ($744.08 million) exchangeable bonds

Select another date: